Home Newsfeeds UBS Maintains Neutral on Coupa Software, Lowers Price Target to $76

UBS Maintains Neutral on Coupa Software, Lowers Price Target to $76

UBS analyst Taylor McGinnis maintains Coupa Software (NASDAQ:COUP) with a Neutral and lowers the price target from $84 to $76.

byBenzinga Newsdesk

August 22, 2022

1 minute read

UBS analyst Taylor McGinnis maintains Coupa Software (NASDAQ:COUP) with a Neutral and lowers the price target from $84 to $76.

Analyst Ratings

4 Analysts Have This to Say About Installed Building Prods

By Benzinga Insights

May 8, 4:01 PM

Installed Building Prods (NYSE:IBP) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent…

IBP

Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder

By Vandana Singh

April 23, 1:28 PM

Neurocrine Biosciences reports Phase 2 data for NBI-1065845 in major depressive disorder. Results show significant improvement in MADRS scores. William Blair sees the potential for $1 billion+ in sales.

NBIX

IceCure Medical Takes Next Major Initiative As It Prepares To Accelerate The Commercialization Of ProSense In U.S. And Canada: Appoints VP Of Sales, North America

By Happy Mohamed

August 28, 8:06 AM

Mr. Shad Good brings nearly 20 years of medical device sales and leadership experience, including as U.S. Senior Director of Sales at a global leader in minimally invasive breast diagnostic and therapeutic

ICCM

CarGurus Stock Has Collapsed — But Analysts Say It’s Actually Outperforming Dire Industry Circumstances: Here’s Why

By Anusuya Lahiri

November 9, 2:40 PM

Needham analyst Chris Pierce reiterated his Buy rating on CarGurus, Inc (NASDAQ: CARG) but cut the price target to $16 from $21 post 3Q22 results that broadly missed consensus and 4Q22 guidance

CARG

UBS Maintains Neutral on Coupa Software, Lowers Price Target to $76

Related Posts

4 Analysts Have This to Say About Installed Building Prods

Neurocrine Biosciences Says Treatment Can Alleviate Several Symptoms Associated With Depressive Disorder

IceCure Medical Takes Next Major Initiative As It Prepares To Accelerate The Commercialization Of ProSense In U.S. And Canada: Appoints VP Of Sales, North America

CarGurus Stock Has Collapsed — But Analysts Say It’s Actually Outperforming Dire Industry Circumstances: Here’s Why